MARÍA CONSUELO DEL
CAÑIZO FERNÁNDEZ-ROLDÁN
Chercheuse dans le période 1993-2017
Publications dans lesquelles il/elle collabore avec MARÍA CONSUELO DEL CAÑIZO FERNÁNDEZ-ROLDÁN (19)
2019
-
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162
2016
-
Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes
PLoS ONE, Vol. 11, Núm. 10
2013
-
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine
Annals of Hematology, Vol. 92, Núm. 11, pp. 1543-1552
2012
-
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression
Pharmacogenetics and Genomics, Vol. 22, Núm. 5, pp. 381-388
2011
-
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Haematologica, Vol. 96, Núm. 3, pp. 375-383
2010
-
Immunomodulatory effect of 5-azacytidine (5-azaC): Potential role in the transplantation setting
Blood, Vol. 115, Núm. 1, pp. 107-121
2009
-
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome
Leukemia, Vol. 23, Núm. 4, pp. 664-672
-
C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome
Leukemia Research, Vol. 33, Núm. SUPPL. 1
-
Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response
Leukemia Research, Vol. 33, Núm. 1, pp. 170-173
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia, Vol. 23, Núm. 8, pp. 1515-1527
-
P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia
Leukemia Research, Vol. 33, Núm. SUPPL. 1
-
P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)
Leukemia Research, Vol. 33, Núm. SUPPL. 1
2005
2004
-
Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities
Leukemia Research, Vol. 28, Núm. 11, pp. 1181-1187
2001
-
Continuous oral cytarabine ocfosfate with interferon-α-2b for patients with newly diagnosed chronic myeloid leukaemia: A pilot study
British Journal of Haematology, Vol. 115, Núm. 3, pp. 541-544
2000
-
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
Annals of Oncology, Vol. 11, Núm. 4, pp. 441-444
-
Cytogenetic abnormalities are associated with immunophenotypic changes in refractory anemias
Blood, Vol. 96, Núm. 11 PART I
-
Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation
Haematologica, Vol. 85, Núm. 4, pp. 403-409
1998
-
The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders
Haematologica, Vol. 83, Núm. 1, pp. 3-7